Enterprise Account Executive, Benchling
+ Equity
Cloud-based platform for biotech R&D
Open for applications
Cloud-based platform for biotech R&D
501-1000 employees
Open for applications
+ Equity
501-1000 employees
Company mission
To unlock the power of biotechnology and empower their global customers to get to milestones & market faster.
Jump to section
Company mission
To unlock the power of biotechnology and empower their global customers to get to milestones & market faster.
Our take
As the pioneer of the R&D Cloud, Benchling offers a cloud-based informatics platform tailored for biotechnology. Its platform enables scientists across the globe to make breakthrough discoveries and bring next-gen biotechnology to market.
There’s a sincerity and consciousness to Benchling’s approach that stands out. This has led to the company being adopted by over 200,000 scientists from 1,000+ companies and 7,500 academic and research institutions globally (including 23andMe, Moderna, and the U.S. Department of Defense).
The rapidly advancing Biotechnology industry was at the forefront of the so-called “fourth industrial revolution”, with the industry driving $2 to $4 trillion per year of economic impact over the next 20 years.
Benchling has put itself in a position of immense value within the industry with its expanding offerings. Off the back of over $400 million in total funding, the company is seeing accelerated growth
Steph
Company Specialist at Welcome to the Jungle
Benefits
- 4 months paid parental leave
- 401k plan
- Pre-tax commuter benefits
- Flexible paid time off
- Work from home opportunities
- 100% premiums covered for health, dental, & vision
- Fertility healthcare and family-forming benefits
Company values
- Constant Curiosity - Like the scientists we serve, we approach life with a sense of constant curiosity
- Scientist First - We’re relentlessly focused on taking a scientist-first approach
- Impact Driven - We commit our time, energy, and resources to efforts that will drive maximum impact
Funding (last 2 of 8 rounds)
Nov 2021
$100m
SERIES F
Apr 2021
$200m
SERIES E
Total funding: $411.9m
This company has top investors
Leadership
Sajith Wickramasekara
(CEO)Sajith studied at MIT before spending 2 years as a Research Assistant at Duke University Medical Centre and Liquidia Technologies. They used this biotechnology understanding to found Benchling in June 2012, serving as CEO since.
Ashu Singhal
(President)They previously co-founded Hotspots.io which was later acquired by Twitter in 2012. After this, became Staff Software Engineer at Twitter for 2 years, leaving to co-found Benchling.
Articles
Jobs (11)
Marketing
Finance, Legal & Compliance